| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/16/1998 | US5766906 Deletion mutation in 5'nontranslated region of viral genome |
| 06/16/1998 | US5766904 A dna fragment of phages virulent towards a streptococcus and capable of conferring resistance to at least one phage; used for making yoghurt and cheeses; sanitation |
| 06/16/1998 | US5766900 Method of regenerating fertile transgenic Zea mays plants from protoplasts |
| 06/16/1998 | US5766899 Complex comprising circumsporozoite region ii-containing polypeptide, nucleic acid binding agent |
| 06/16/1998 | US5766897 Cysteine-pegylated proteins |
| 06/16/1998 | US5766892 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system together with an antibiotic |
| 06/16/1998 | US5766886 Modified antibody variable domains |
| 06/16/1998 | US5766884 Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic animals |
| 06/16/1998 | US5766883 Fusion |
| 06/16/1998 | US5766882 recombinant poxviruses with foreign DNA in essential regions |
| 06/16/1998 | US5766880 Lung cancer |
| 06/16/1998 | US5766879 DNA encoding 5-HT4 serotonin receptors and uses thereof |
| 06/16/1998 | US5766878 Polynucleotides encoding a transcriptional response regulator of streptococcus pneumoniae |
| 06/16/1998 | US5766877 Genes encoding art, an agouti-related transcript |
| 06/16/1998 | US5766866 Lymphocyte chemoattractant factor and uses thereof |
| 06/16/1998 | US5766863 Kinase receptor activation assay |
| 06/16/1998 | US5766857 Isolation and use of fibronectin receptor |
| 06/16/1998 | US5766856 Diagnostic method for evaluating advanced glycosylation endproducts using MAC-2 receptor |
| 06/16/1998 | US5766855 Peptide nucleic acids having enhanced binding affinity and sequence specificity |
| 06/16/1998 | US5766853 Method for identification of high affinity nucleic acid ligands to selectins |
| 06/16/1998 | US5766851 Susceptibility gene for obesity and type II diabetes mellitus |
| 06/16/1998 | US5766850 Human β2 integrin α subunit |
| 06/16/1998 | US5766849 Methods of amplifying nucleic acids using promoter-containing primer sequence |
| 06/16/1998 | US5766848 Methods for identifying compounds which specifically bind a human betaine/GABA transporter |
| 06/16/1998 | US5766846 Methods of screening for compounds which inhibit soluble β-amyloid peptide production |
| 06/16/1998 | US5766845 Immunoreactive polypeptide compositions |
| 06/16/1998 | US5766844 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160. |
| 06/16/1998 | US5766840 Purified antibody preparation |
| 06/16/1998 | US5766838 Manual quantitating the number of leukocyte binding tissue cell over a defind are of tissue sample section |
| 06/16/1998 | US5766609 Administering to the animal to reduce protease activity of fleas feeding on said animal; antifertility agents; veterinary medicine |
| 06/16/1998 | US5766608 DNA molecules which encode the fimbrin protein of Haemophilus influenzae |
| 06/16/1998 | US5766607 Production of a vaccine against bovine keratoconjuctivitis |
| 06/16/1998 | US5766606 Genetic manipulation of gene encoding a group b streptococcus surface protein so that it is no longer able to bind to human iga |
| 06/16/1998 | US5766602 Recombinant packaging defective Sindbis virus vaccines |
| 06/16/1998 | US5766601 Cross-reactive influenza a immunization |
| 06/16/1998 | US5766599 Attenuated virus; genetic engineering |
| 06/16/1998 | US5766598 Immunology response to lentivirus gene |
| 06/16/1998 | US5766597 Vaccines providing immunity against plasmodium infections |
| 06/16/1998 | US5766594 Dna sequences encoding a polypeptide reactive with nti-mycoplasma gallisepticum chicken sera; expressed by a genetically engineered cell |
| 06/16/1998 | US5766593 Anti-inflammatory CD14 peptides |
| 06/16/1998 | US5766591 Methods and compositions useful for inhibition of angiogenesis |
| 06/16/1998 | US5766586 Gram-positive bacteria replicon |
| 06/16/1998 | US5766585 Infecting bone marrow cells with recombinant retroviral expression vector that contains a polynucleotide sequence coding a biologically active interleukin receptor antagonist protein, injecting into host; antiinflammatory agents |
| 06/16/1998 | US5766581 Increasing platelet number with polypeptide molecules attached to polyethylene glycol |
| 06/16/1998 | US5766570 Lymphocyte activation antigens and antibodies thereto |
| 06/16/1998 | US5765538 Pump device for a fuel vapor retention system of an internal combustion engine |
| 06/16/1998 | CA2128111C Process for isolating lactoferrin and lactoperoxidase from milk and milk products, and products obtained by such process |
| 06/12/1998 | CA2192754A1 Nur-re a response element which binds dimers of nur nuclear receptors and method of use therefor |
| 06/11/1998 | WO1998025144A1 Methods and cell lines for identification of regulators of integrin activation and compositions identified thereby |
| 06/11/1998 | WO1998025142A1 Alarm related peptides and nucleic acids and diagnosis using them |
| 06/11/1998 | WO1998024931A1 Method for the identification of peptides that recognize specific dna sequences |
| 06/11/1998 | WO1998024927A1 Compositions and methods for administering pneumococcal dna |
| 06/11/1998 | WO1998024924A1 Genetic modification of primate hemopoietic repopulating stem cells |
| 06/11/1998 | WO1998024923A1 Inactivation of hiv co-receptors as therapy for hiv infection |
| 06/11/1998 | WO1998024922A1 Insulin-like growth factor i (igf-i) expression system and methods of use |
| 06/11/1998 | WO1998024921A1 Syndecan enhancer element and its use for targeting gene expression |
| 06/11/1998 | WO1998024919A1 Genetically modified pseudomonas strains with enhanced biocontrol activity |
| 06/11/1998 | WO1998024916A1 Novel calpaines, production and use thereof |
| 06/11/1998 | WO1998024915A1 Protein phosphatase 2a subunit polypeptide |
| 06/11/1998 | WO1998024912A2 Recombinant plague vaccine |
| 06/11/1998 | WO1998024911A2 Mutants of streptococcal toxin a and methods of use |
| 06/11/1998 | WO1998024910A2 Mutants of streptococcal toxin c and methods of use |
| 06/11/1998 | WO1998024909A1 Chaperone fragments |
| 06/11/1998 | WO1998024908A1 Human chemokine beta-13 |
| 06/11/1998 | WO1998024907A1 Novel protein with chemokine activity |
| 06/11/1998 | WO1998024906A2 Isolated mammalian monocyte cell genes; related reagents |
| 06/11/1998 | WO1998024905A2 Secreted proteins and polynucleotides encoding them |
| 06/11/1998 | WO1998024904A2 Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders |
| 06/11/1998 | WO1998024903A1 Isolation and use of erythroid differentiation and denucleation factors |
| 06/11/1998 | WO1998024902A1 Adaptor protein frs2 and related products and methods |
| 06/11/1998 | WO1998024901A1 Lung growth factor variant |
| 06/11/1998 | WO1998024900A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
| 06/11/1998 | WO1998024899A1 IgA NEPHROPATHY-ASSOCIATED GENE |
| 06/11/1998 | WO1998024898A2 Therapeutic composition comprising the kal protein and use of the kal protein |
| 06/11/1998 | WO1998024897A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions |
| 06/11/1998 | WO1998024896A2 Muteins of obese protein |
| 06/11/1998 | WO1998024895A1 Receptor belonging to the tnf/ngf receptor family |
| 06/11/1998 | WO1998024894A2 Pkd1 fragments with bonding areas for pkd1-specific antibodies |
| 06/11/1998 | WO1998024893A2 TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL VH AND Vλ REGIONS AND ANTIBODIES PRODUCED THEREFROM |
| 06/11/1998 | WO1998024885A1 Helicobacter pylori antigen having an apparent molecular weight of 16±2 kda, a specific antibody, and its use for the detection of said antigen |
| 06/11/1998 | WO1998024884A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 06/11/1998 | WO1998024881A1 Mutant ob receptors and nucleotides encoding them |
| 06/11/1998 | WO1998024818A1 Novel trh receptor |
| 06/11/1998 | WO1998024817A1 Novel dna, novel protein, and novel antibody |
| 06/11/1998 | WO1998024816A1 Synthetic bi-epitope compounds useful as standard measure in biological dosage of troponin i |
| 06/11/1998 | WO1998024815A1 Novel protein |
| 06/11/1998 | WO1998024813A2 Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives |
| 06/11/1998 | WO1998024812A2 A6la5a12 polypeptides and polynucleotides and methods of use therefor |
| 06/11/1998 | WO1998024811A2 Vascular endothelial growth factor |
| 06/11/1998 | WO1998024810A2 Vertebrate homologues of unc-53 protein of c. elegans |
| 06/11/1998 | WO1998024807A2 Somatostatin antagonists |
| 06/11/1998 | WO1998024482A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them |
| 06/11/1998 | WO1998024475A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
| 06/11/1998 | WO1998024464A1 Specific antagonists for glucose-dependent insulinotropic polypeptide (gip) |
| 06/11/1998 | WO1998024463A2 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
| 06/11/1998 | WO1998024300A1 Carotenoid-associated proteins useful for high carotenoid accumulation and production in plants and other organisms |
| 06/11/1998 | WO1998024297A1 Hypersensitive response induced resistance in plants by seed treatment |
| 06/11/1998 | WO1998012910A3 Novel CREBa isoform |
| 06/11/1998 | WO1998006749A3 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 06/11/1998 | WO1998002461A3 Liquid phase peptide syntheses of kl-4 pulmonary surfactant |